Cardiometabolic Medicine

@cardiomet_CE on Twitter


Faculty                                  Relationship Identified With:
Roopen AryaSpeaker’s Bureau: Sanofi, Cardinal Health
Fawaz Al-MuftiConsultant: UCB, Stryker, Penunbra, Cerenovus, AstraZeneca
Casey Albin, MDNothing to Disclose
Sophia AmbrusoConsultant: AstraZeneca
Dr. Sonia AnandConsulting and speaker fees: Bayer AG, Janssen Pharmaceuticals
Alessia ArgiròNothing to Disclose
Christos Argyropoulos MD, PhD, FASNConsultant: Baxter Healthcare, Bayer
Sara AzimiNothing to Disclose
Christie Ballantyne, MDGrant Research Support: Abbott Diagnostic, Akcea, Amgen, Arrowhead, Esperion, lonis, Novartis, Regeneron, Roche Diagnostic, NIH, AHA, ADA; Consultant- Abbott Diagnostics, Althera, Amarin, Amgen, Arrowhead, Astra Zeneca, Denka Seiken, Esperion, Genentech, Gilead, Illumina, Matinas BioPharma Inc, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic, Sanofi-Synthelabo 
Geoffrey Barnes, MD, MScConsultant: Pfizer, Briston-Myers Squib, Janssen, Boston Scientific, Abbott Vascular; Board of Directors: Anticoagulation Forum
Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACPNothing to Disclose
Sheila Bermejo GarcíaReports honorarium for conferences, consulting fees, and advisory boards from AstraZeneca, Boehringer and Mundipharma
Deepak L. Bhatt, MDGrant/Research Support: Abbott; Afimmune Limited; Amgen Inc.; AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Cardax, Inc.; CHIESI USA, Inc.; CSL Behring; Eli Lilly and Company; Eisai Co., Ltd.; Ethicon; Ferring Pharmaceuticals; Forest Laboratories; Fractyl Laboratories, Inc.; Idorsia Pharmaceuticals Ltd; Ironwood Pharmaceuticals, Inc.; Ischemix; Lexicon Pharmaceuticals, Inc.; Medtronic; Pfizer; PhaseBio Pharmaceuticals, Inc.; PLx Pharma Inc.; Regeneron Pharmaceuticals; Sanofi; Synaptic, The Medicines Company
Snehal H. Bhatt, PharmDSpeaker’s Bureau: Janssen Global Services, LLC
Bryan BolingNothing to Disclose
Allison E Burnett PharmD, PhC, CACPConsultant: Abiomed
Mauricio G. Cohen, MDConsultant/Advisor: Abiomed; AstraZeneca Pharmaceuticals; Medtronic; Merit Medical Systems; Terumo Medical Corporation Speaker’s Bureau: Abiomed; Medtronic; Merit Medical Systems; Terumo Medical Corporation Ownership: Accumed Radial Systems
A. John CammConsultant: Milestone, InCarda, Acesion, Huy Bio, Sanofi, Boston Scientific, Abbott, Medtronic
Christopher P. Cannon, M.D.Research Grants from: Amgen, Better Therapeutics, Boehringer-Ingelheim (BI), Daiichi Sankyo, Merck, Novo Nordisk, Pfizer; Consulting fees from Amryt/Chiesi, Alnylam, Amarin, Amgen, Applied Therapeutics, Ascendia, Biogen, BI, BMS, Eli Lilly, Janssen, Lexicon, Merck, Milestone, Pfizer, Rhoshan, Sanofi; Serves on the Data and Safety Monitoring Boards for the Applied Therapeutics, Areteia and Novo Nordisk.  
Clara García CarroTravel and congress fees support from AstraZeneca, Esteve, NovoNordisk, Boehringer Ingelheim Lilly, Astellas, Otsuka, Novartis, Astellas, and Baxter; Scientific lectures, advisory boards and scientific committees organized by AstraZeneca, Boehringer Ingelheim Lilly, Mundipharma, Esteve and NovoNordisk
Richard Choi DONothing to disclose
Ricardo Correa, MDNothing to disclose
Claire DaviesSpeaker: NovoNordisk, CMM, Astra Zeneca, CareFlow Medicines Management, Diabetes Professional Care, NAPP; Advisor: MTech Access, Roche; Author: Green Light Pharmacy
Melanie Davies CBE, MB ChB, MD, FRCP, FRCGP, FMedSciConsultant, advisory board member, speaker and received grant: Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sanofi; Board Member: Lexicon, Pfizer, ShouTi Pharma Inc; Speaker: AstraZeneca, Napp Pharmaceuticals, Novartis, Janssen
Tejas DesaiNothing to disclose
Dave L. Dixon, PharmaDResearch Funding: Boehringer Ingelheim
Thor EdvardsenNothing to disclose
Kevin Fernando, MD Consultant/Advisor: AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; MSD Pharmaceuticals; NAPP Pharmaceuticals Limited; Novo Nordisk A/S; Sanofi Speaker’s Bureau: AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; MSD Pharmaceuticals; NAPP Pharmaceuticals Limited; Novo Nordisk A/S; Sanofi; Daiichi Sankyo, Amgen & Amarin
Ines FonsecaSpeaker, conference support: Novo Nordisk; Conference support: Lilly; Speaker: AstraZeneca
Dr GIUSEPPE GALATINothing to disclose
Dr Robert P. GiuglianoClinical Trials/Research Support: Amgen, Anthos Therapeutics, Daiichi Sankyo; Honoraria for Lectures / CME Programs: Amgen, Centrix, Daiichi Sankyo, Dr. Reddy’s Laboratories, Medical Education Resources (MER), Medscape, Menarini, Merck, Pfizer, SAJA Pharmaceuticals, Servier, Shanghai Medical Telescope, Voxmedia; Consultant: Amarin, Amgen, Boston Scientific, CryoLife S, CSLBehring, CVS Caremark, Daiichi Sankyo, Esperion, Gilead, Hengrui, Inari, Janssen, Novartis, Pfizer, PhaseBio Pharmaceuticals, St. Lukes, Samsung
Dr. Ilana HalperinSpeaker, Consultant: Dexcom Canada, Sanofi; Speaker: Sanofi; Consultant: Abbott Diabetes Canada
Will Herrington, MA, MBBS, MD, FRCPPersonal fellowship and institutional grant funding: Medical Research UK and Kidney Research UK.
Research support: Boehringer Ingelheim and Lilly.
I follow a departmental policy to decline any honoraria from the pharmaceutical or food industry.
Dr. Patrick Holmes MB BS, MSc, DipTher, MRCGPConsultant: AstraZeneca, NovoNordisk, Eli Lilly, Abbot; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, NovoNordisk, Eli Lilly; Research Grant Recipient: NovoNordisk, Roche
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCPSpeaker: Dexcom, Abbott, Novo Nordisk ; Consultant: Insulet, Lilly, Cequr, Medtronic, Sanofi
Noah Ivers, MD, CCFP, PhDEvaluation consulting and speakers fee: Novo Nordisk; Evaluation consulting: Merck
Cynthia JackeviciusNothing to disclose
Stefan JamesClinical Trial Steering Committee: AstraZeneca, Jansen, Bayer, Elixir; Consulting: Medtronic
Sanjit JollyInstitutional Research Grant: Boston Scientific; Consultant Fee: Medtronic
Sergio Emanuel Kaiser, M.D., MSc, PhD, FACC, FESCSpeaker, Consultant, Investigator: Novo Nordisk; Speaker and Consultant: Astrazeneca; Speaker: Novartis, Bayer, Behringer Ingelheim, Merck Serono, Daiichi Sankyo
Darae Ko, MD, MScAdvisory Board: Eagle Pharmaceuticals, Inc; Research Grant: Boston Scientific Corp; Speaker: CME Outftters, LLC
Mikhail Kosiborod, MDConsultant/Advisor: Alnylam; Amgen Inc.; Applied Therapeutics; AstraZeneca Pharmaceuticals; Bayer AG; Boehringer Ingelheim International GmbH; Cytokinetics; Eli Lilly and Company; Janssen Global Services, LLC; Lexicon; Merck & Co., Inc. (Diabetes and Cardiovascular); Novo Nordisk A/S; Pharmacosmos; Sanofi; Vifor Pharma; Grant/Research Support: AstraZeneca Pharmaceuticals; Boehringer Ingelheim International GmbH
Edgar V. LermaSpeaker’s Bureau: AstraZeneca; Bayer; Otsuka
Consultant: Vifor; Otsuka; Bayer
Jane A. Linderbaum, MS APRN, CNP, FACC, FPCNANothing to disclose
Niels D. Martin, MD, FACS, FCCMConsultant/Advisor/Speaker: AstraZeneca; Consultant: Nestle, FloBio
Stephan A. Mayer, MD, FCCM, FNCS Advisory Board: AstraZeneca
Taher Modarressi, MDSpeakers’ Bureau: AstraZeneca
Ahmad MasriResearch Grants: Pfizer, Akcea, Ionis, Ultromics; Honoraria: Pfizer, Alnylam, Eidos, Akcea, Ionis, Cytokinetics, BMS; Consultant: Attralus, Tenaya, Ionis
Roxana Mehran, MDConsultant/Advisor: Abbott; Boston Scientific; Bristol Myers Squibb; CardiaWave; CHIESI USA, Inc.; Concept Medical; CineMed; Daiichi Sankyo, Inc.; Idorsia Pharmaceuticals; Janssen Global Services, LLC; Medtronic; Medscape; Novartis AG; Regeneron Pharmaceuticals; Spectranetics/Philips/Volcano Corporation; WebMD Grant/Research Support: Abbott; Abiomed; Applied Therapeutics; AstraZeneca Pharmaceuticals; Bayer AG; Bristol Myers Squibb; Cerecor Inc; CHIESI USA, Inc.; Concept Medical; CSL Behring; Daiichi Sankyo, Inc.; Medtronic; Novartis AG; OrbusNeich; Zoll Medical Corporation Speaker’s Bureau: Boston Scientific; CineMed; Janssen Global Services, LLC; Medscape; WebMD Equity: Applied Therapeutics; Elixir Medical; STEL
Erin D. MichosAdvisory Board: Novartis, Esperion, Amarin, AstraZeneca
Dr Ahmed Mohsen, MD, MSc. Nothing to disclose
Nicholas Morris, M.D.Nothing to disclose
Denisa MuraruSpeaker: GE Healthcare, Philips Medical Systems.
James Novak, MD PhD FASN FNKF FACP Nothing to disclose
Katelyn O’Brien, PharmD, BCPS, CDCESNothing to disclose
Iacopo OlivottoConsultant: BMS, Cytokinetics, Amicus, Shire Takeda, Genzyme, Rocket Pharma, Tenaya
Charles V. Pollack Jr., MD (Course Chair) Grant/Research Support: AstraZeneca Pharmaceuticals, eXIthera Pharmaceuticals, Provepharm US; Consultant/Advisor: AstraZeneca Pharmaceuticals, eXIthera Pharmaceuticals, Provepharm US, PhaseBio Pharmaceuticals, orexo, VERO Biotech, Milestone Pharmaceuticals
Richard Pratley, MD Consultant/Advisor: Merck & Co., Inc.; Novo Nordisk A/S; Pfizer; Sanofi; SCOHIA PHARMA, Inc.; Sun Pharmaceutical Industries Ltd. Grant/Research Support: Hanmi Pharmaceutical Co.; Metavention; Novo Nordisk A/S; Poxel SA Speaker’s Bureau: Allergan; Novo Nordisk A/S
Dr. Amar PuttannaSpeaker’s Bureau: Novo Nordisk, Lilly-Boehringer Ingelheim, Sanofi, Daiichi- Sankyo, AstraZeneca; Consulting: Sanofi
Brian Rifkin, MDNothing to disclose
Leyla Elif SadeNothing to disclose
Katherine SandquistNothing to disclose
Naveed SattarConsulting/speaker honoraria: Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, MSD, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, Sanofi; Grants: AstraZeneca, Boehringer Ingelheim, Novartis, Roche Diagnostics 
Dr. Sanjiv ShahGrant: National Institutes of Health, Actelion, AstraZeneca, Crovia, Novartis, Pfizer; Consultant: Abbott, Actelion, AstraZeneca, Amgen, Aria CV, Axon Therapies, Bayer, Boehringer-Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cardiora, Coridea, CVRx, Cyclerion, Cytokinetics, Edwards Lifesciences, Eidos, Eisai, Imara, Impulse Dynamics, GSK, Intellia, Ionis, Ironwood, Lilly, Merk, MyoKardia, Novartis, Novo Nordisk, Pfizer, Prothena, Regeneron, Rivus, Sanofi, Sardacor, Shifamed, Tenax, Tenaya, United Theraputics
Pam R. Taub, MD, FACC, FAPSCConsultant: Amgen, Medtronic, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, Amarin
Dr. Ritu ThammanConsultant: Bayer
Paul D. Thompson, MDConsultant: Amgen, Regeneron, Esperion, and Sanofi; Research Support: Sanofi, Regeneron, Esperion, Amarin, Norvartis and Pfizer; Owns Stock: Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, and Sarepta; Provided Legal Consultation on exercise-related cardiac events and statin myopathy
Carlo Nemesio Trinidad, MD, FPCP, FPSNSpeaker: AstraZeneca; Corbridge Philippines; Otsuka; Sanofi
Hartzell V. SchaffNothing to disclose
Dr Sourabh SharmaNothing to disclose
Deborah Siegal MD MSc FRCPCHonoraria: BMS-Pfizer, Leo Pharma, Servier
Natalie Staplin, PhDResearch funding paid to institution for EMPA-KIDNEY trial: Boehringer Ingleheim; Eli Lilly and Company. Research funding paid to institution ASCEND-PLUS trial: Novo Nordisk.
Alex C. Spyropoulos, MD, FACP, FCCP, FRCPCResearch Funding/ Consultant: Janssen; Consultant: Bristol Myers Squibb, Boehringer Ingelheim, Atlas Group, Alexion, Bayer
Dr. Alfonso Valle, MD, PhDNothing to disclose
Dr. Harriette Van SpallResearch Funding: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
Prof. Dr. Frederik H. VerbruggeConsultant: AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb Belgium, Roche Diagnostics, Qompium; Speaker: Abiomed, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb Belgium, Menarini Group, Novartis Pharma, Novo Nordisk, Pfizer, Qompium; Institution received grants: Roche Diagnostics; Travel grants: Abbott Laboratories, Bayer, Novo Nordisk, Pfizer
Jason Weatherald, MDAdvisory board participant: Acceleron; Advisory board participant, speaker’s bureau, research grant recipient: Janssen/Actelion; Shareholder: Precision Lung Consultants & Diagnostics; Clinical Trial investigator: Merck
Susan Weiner, MS, RDN, CDCES, FADCESNothing to Disclose

All relevant financial relationships with ineligible companies for this educational content have been mitigated.